Jan Mikkelsen is the founder of Ascendis Pharma. Latest round: IPO. Backed by RA Capital Management, Viking Global Investors, Sunstone Capital.
Jan Møller Mikkelsen is the founder, President, and CEO of Ascendis Pharma, which he established in Copenhagen, Denmark in December 2007. He founded the company around the acquisition of Complex Biosystems GmbH, which invented the TransCon technology. He holds a 3.2% personal ownership stake in Ascendis Pharma.
Full founder directory · Investor directory · Company funding database · Fundraising library